The Mycobacterial Cohort Study (MyCoS) stores biomaterial (plasma, serum, PBMC’s, PAXgene and DNA) from patients being treated at Radboudumc for a mycobacterial infection, together with data about the patient's disease course. Through the MyCoS biobank a platform will be created to answer diagnostic, pathophysiological and prognostic questions about mycobacterial infections.
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
TETRO-trial30 March 2023
The TETRO-trial is a study on a new treatment for compulsive/obsessive-compulsive disorder.read more
Archipelago30 March 2023
Archipelago of Ovarian Cancer Research (AOCR) is a national platform for centralizing and expanding scientific research into ovarian cancer.read more
Theme Biobank and collections of Health RI launched a new project to develop a novel Dutch Biobank Standard30 March 2023
In February 2023 the theme Biobanks and Collections of Health-RI launched a new project entitled: “Dutch biobanking standard: towards harmonized, evidence-based collection, processing and storage of human biomaterials”.read more
Health-RI receives definitive follow-up funding from the National Growth Fund30 March 2023
The full funding of a total of 69 million euros has been definitively awarded to Health-RI, the national health data infrastructure for research and innovation.read more
Control over Human Biomaterials Act [Wet zeggenschap lichaamsmateriaal] (Wzl)19 July 2022
The Ministry of Health, Welfare and Sport (VWS) is currently preparing a Control over Human Biomaterials Act [Wet zeggenschap lichaamsmateriaal] (Wzl) which will serve in the future as a specific legal framework for the (further) use of body tissue for medical scientific research.read more